New England Journal of Medicine· 2014Q1

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

Nezam H. Afdhal, K. Rajender Reddy, David R. Nelson, Eric Lawitz et al.

1,308citations
Q1SCImago
2014year

Short summary

A 12-week regimen of ledipasvir-sofosbuvir achieved a 94% sustained virologic response rate in patients with HCV genotype 1 who failed prior interferon-based therapy.

AI-generated from the title and abstract; the full text is not read.

TakeawaysIn the app

Key pointsIn the app

Ask the paperIn the app

The rest is in the Pofolia app

Takeaways, key points and questions to the paper; new summaries every day for your field. Free.

Get it on Google Play Download on the App Store

Field: Hepatology

HepatologyMedicine